Inspired by the reported cross-talk between the IGF1R and EGFR signaling pathways [13-17], we blocked both EGFR and IGF1R in MPNST cells to evaluate the possibility of synergistic or antagonistic effects. The gene discussed is EGFR; the disease is malignant peripheral nerve sheath tumor.